Fenucure Medical ApS: Financial statements 2014
CVR: 28486871
Source: annual report 2014, Danish Business Authority
01/07/2013 – 30/06/2014
Fenucure Medical ApS (CVR 28486871) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK -10,000 and a net result of DKK -25,582 compared with DKK -152,481 the year before. Equity in the 2014 report amounted to DKK -177,568.
- Gross Profit
- DKK -10,000
- Profit/Loss
- DKK -25,582
- Equity
- DKK -177,568
- Total Assets
- DKK 704,662
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
As of October 13, 2014, Philip Xavier Severin Møller is registered as director of Fenucure Medical ApS.
About Fenucure Medical ApS
Fenucure Medical ApS is a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2005. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named V-BIOTEK ApS and VIND INVEST ApS. The management consists of Christian Hother Sørensen. The board consists of Nicolai Fink Gundersen (chair), Alex Gundersen, Mogens Viktor Madsen and Niels Christian Beck Vase. The company is owned by V-BIOTEK HOLDING ApS, Redwood Foundation ApS and Alex Gundersen Assens ApS. The company has 0 employees (2018). In 2025, the company reported a gross profit of DKK -1,214,608 and a net result of DKK -3,201,378 compared with DKK -1,529,007 the year before. Equity in the 2025 report amounted to DKK 593,861.